2Martin TJ, Moseley JM. Mechanisms in the skeletal complications of breast cancer [ J]. Endoer Relat Cancer,2000,7:271 - 284.
3Huber S,Ulsperger E,Gomar C. et al. Osseous metastases in breast cancer: radiographic monitoring of therapeutic response [ J]. Anticancer Res ,2002,22 : 1279 - 1288.
4Soiomayer EF, Diel IJ. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis [ J]. Breast Cancer Res Treat,2000,59:271 -278.
5Mundy GR. Metastasis to hone:causes, consequences and therapeutic opportunities[J]. Nat Rev Cancer,2002,2:584 -593.
6Mundy GR, Martin TJ. Pathophysiology of skeletal complications of cancer[ A]. Mundy GR , Martin TJ, eds. Physiology and pharmacology of bone [M]. Berlin :Springer-Verlag,1993:641 -671.
7Colleoni M, ONeill A , GOldhirsch A , et al. Identifying breast cancer patients at high risk for bone metastases [ J]. J Clinoncol, 2000,18( 23 ) :3925 -3935.
8Mitsuru K , Masataka Y, Fujio K, et al. What do breast cancer patients benefit from staging bone scintigraphy[ J ] ? Jpn J Clinoncol, 2001,31 ( 6 ):263-269.
9Barak V, Nisman B, Roisman I, et al. TPS in assessing response to therapy and prognosis of breast cancer patients treated with interferons[J]. J Tumor Marker Oncol, 1997, 12:17.
10[1]Martin TJ, Moseley JM. Mechanisms in the skeletal complications of breast cancer. Endocr Relat Cancer., 2000,7: 271 - 284.
